• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用高效液相色谱-紫外吸收检测法测定人尿中希莫洛芬及其代谢物。

Determination of ximoprofen and its metabolites in human urine by high-performance liquid chromatography with ultraviolet absorbance detection.

作者信息

Morris G R, Walmsley L M, Brodie R R, Chasseaud L F

机构信息

Department of Metabolism and Pharmacokinetics, Huntingdon Research Centre Ltd., U.K.

出版信息

J Chromatogr. 1990 Sep 14;530(2):377-85. doi: 10.1016/s0378-4347(00)82340-3.

DOI:10.1016/s0378-4347(00)82340-3
PMID:2079512
Abstract

A simple, sensitive and selective method for the determination of ximoprofen and its keto and hydroxy metabolites in human urine has been developed using high-performance liquid chromatography in the reversed-phase mode. The limit of reliable determination of ximoprofen and each of its metabolites in urine is about 1 microgram/ml (4 nmol/ml). The method has been applied to urine samples obtained from human volunteers after administration of single intravenous doses of 30 mg of ximoprofen and about 70% dose was accounted for in terms of these compounds and their glucuronic acid conjugates.

摘要

已开发出一种简单、灵敏且具选择性的方法,采用反相高效液相色谱法测定人尿中的希莫洛芬及其酮类和羟基代谢物。尿中希莫洛芬及其每种代谢物的可靠测定限约为1微克/毫升(4纳摩尔/毫升)。该方法已应用于单次静脉注射30毫克希莫洛芬后从人体志愿者获取的尿样,这些化合物及其葡萄糖醛酸共轭物约占给药剂量的70%。

相似文献

1
Determination of ximoprofen and its metabolites in human urine by high-performance liquid chromatography with ultraviolet absorbance detection.采用高效液相色谱-紫外吸收检测法测定人尿中希莫洛芬及其代谢物。
J Chromatogr. 1990 Sep 14;530(2):377-85. doi: 10.1016/s0378-4347(00)82340-3.
2
The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
Xenobiotica. 1990 Mar;20(3):233-46. doi: 10.3109/00498259009046843.
3
Determination of trimethoprim metabolites including conjugates in urine using high-performance liquid chromatography with combined ultraviolet and electrochemical detection.采用高效液相色谱结合紫外和电化学检测法测定尿液中包括结合物在内的甲氧苄啶代谢物。
J Chromatogr. 1984 Feb 10;305(2):391-9. doi: 10.1016/s0378-4347(00)83353-8.
4
Stereospecific high-performance liquid chromatographic assay of pirprofen enantiomers in rat plasma and urine.大鼠血浆和尿液中吡洛芬对映体的立体特异性高效液相色谱测定法。
J Chromatogr. 1992 Jun 10;577(2):317-24. doi: 10.1016/0378-4347(92)80253-m.
5
Simultaneous quantitative determination of the major phase I and II metabolites of ibuprofen in biological fluids by high-performance liquid chromatography on dynamically modified silica.通过在动态改性硅胶上的高效液相色谱法同时定量测定生物流体中布洛芬的主要I相和II相代谢物。
J Chromatogr B Biomed Sci Appl. 1997 Aug 29;696(2):235-41. doi: 10.1016/s0378-4347(97)00239-9.
6
High-performance liquid chromatographic determination of pirprofen and five of its metabolites in human plasma without hydrolysis and in human urine before and after chemical hydrolysis.高效液相色谱法测定人血浆中吡洛芬及其五种代谢物(无需水解)以及人尿液中化学水解前后的吡洛芬及其五种代谢物。
J Chromatogr. 1989 Oct 27;495:195-203. doi: 10.1016/s0378-4347(00)82621-3.
7
Determination of phase II drug metabolites in equine urine by micellar electrokinetic capillary chromatography.胶束电动毛细管色谱法测定马尿中Ⅱ相药物代谢物
J Chromatogr A. 1996 Sep 20;745(1-2):155-63. doi: 10.1016/0021-9673(96)00380-9.
8
Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
J Pharm Sci. 1985 Nov;74(11):1203-14. doi: 10.1002/jps.2600741114.
9
Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography.高效液相色谱法同时测定人血浆中醋氯芬酸及其三种代谢物
Biomed Chromatogr. 2003 Jun;17(4):268-75. doi: 10.1002/bmc.243.
10
Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states.抗炎药物西莫洛芬在健康受试者及疾病状态下的药代动力学。
Eur J Clin Pharmacol. 1991;40(1):101-6. doi: 10.1007/BF00315147.